OĞUZÜLGEN, İ. K. Et Al. 2009. The Role of Plasminogen Activator Inhibitor 1 Polymorphism Factor V Leiden and Prothrombin 20210 Mutations in Pulmonary Thromboembolism. Clinical And Applied Thrombosis-Hemostasis , vol.15, no.1 , 73-77.

OĞUZÜLGEN, İ. K., YILMAZ, E., YILMAZ, Ş., FERDA ÖNER, E., EKİM, N. N., DEMİR, N., ... NUMAN, N.(2009). The Role of Plasminogen Activator Inhibitor 1 Polymorphism Factor V Leiden and Prothrombin 20210 Mutations in Pulmonary Thromboembolism. Clinical And Applied Thrombosis-Hemostasis , vol.15, no.1, 73-77.

OĞUZÜLGEN, İPEK Et Al. "The Role of Plasminogen Activator Inhibitor 1 Polymorphism Factor V Leiden and Prothrombin 20210 Mutations in Pulmonary Thromboembolism," Clinical And Applied Thrombosis-Hemostasis , vol.15, no.1, 73-77, 2009

OĞUZÜLGEN, İPEK K. Et Al. "The Role of Plasminogen Activator Inhibitor 1 Polymorphism Factor V Leiden and Prothrombin 20210 Mutations in Pulmonary Thromboembolism." Clinical And Applied Thrombosis-Hemostasis , vol.15, no.1, pp.73-77, 2009

OĞUZÜLGEN, İ. K. Et Al. (2009) . "The Role of Plasminogen Activator Inhibitor 1 Polymorphism Factor V Leiden and Prothrombin 20210 Mutations in Pulmonary Thromboembolism." Clinical And Applied Thrombosis-Hemostasis , vol.15, no.1, pp.73-77.

@article{article, author={İPEK KIVILCIM OĞUZÜLGEN Et Al. }, title={The Role of Plasminogen Activator Inhibitor 1 Polymorphism Factor V Leiden and Prothrombin 20210 Mutations in Pulmonary Thromboembolism}, journal={Clinical And Applied Thrombosis-Hemostasis}, year=2009, pages={73-77} }